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Background. Nonadherence to medication is a burden to the US health care system and is associated with poor clinical out-
comes. Data on outpatient parenteral antimicrobial therapy (OPAT) treatment plan adherence are lacking. The purpose of this study 
is to determine the rate of nonadherence and factors associated with it.
Methods. We surveyed patients discharged from a tertiary hospital on OPAT between February and August 2019 about their 
baseline characteristics, OPAT regimen, adherence, and experience with OPAT.
Results. Sixty-five patients responded to the survey. The median age was 62 years, and 56% were male. The rate of reported 
nonadherence to intravenous (IV) antibiotics was 10%. Factors associated with nonadherence to IV antibiotics included younger 
age, household income of <$20 000, and lack of time for administering IV antibiotics (30 vs 64 years, P < .01; 83% vs 20%, P < .01, 
and 33% vs 4%, P = .04, in the nonadherent vs adherent groups, respectively), while less frequent administration (once or twice 
daily) and having friend or family support during IV antibiotic administration were associated with better adherence (17% vs 76%, 
P < .01, and 17% vs 66%, P = .03, in the nonadherent vs adherent groups, respectively). Most patients attended their infectious 
diseases clinic visits (n = 44, 71%), and the most commonly cited reasons for missing an appointment were lacking transportation 
(n = 12, 60%), not feeling well (n = 8, 40%), and being unaware of the appointment (n = 6, 30%).
Conclusions. Less frequent antibiotic dosing and better social support were associated with improved adherence to OPAT. In 
contrast, younger age, lower income, and lack of time were associated with nonadherence.
Keywords.  OPAT; adherence; no-show; compliance; social support.
Outpatient parenteral antimicrobial therapy (OPAT) is an ef-
fective modality for treating patients with serious infectious 
diseases (ID) outside of a hospital setting [1, 2]. By allowing 
patients to receive treatment at home, OPAT avoids expenses 
associated with prolonged hospital stays, reduces exposure 
to nosocomial pathogens, and allows patients to maintain a 
normal lifestyle [3]. OPAT is generally considered safe but re-
quires close monitoring for therapy-related complications and 
treatment failure [4]. Past studies have shown that readmission 
rates for OPAT patients range from 6% to 26% [5–7]. These re-
admissions can result from worsening infection, line complica-
tions, or comorbidities [5–7].
Medication nonadherence is a burden to the US health 
care system, leading to higher health care costs and worse pa-
tient outcomes. The annual cost of medication nonadherence 
in the United States is estimated to be $300 billion [8, 9]. 
Nonadherence to oral antibiotics has been linked to poor clin-
ical outcomes such as infection relapses, need for new anti-
biotics, and additional medical procedures [10]. Factors that 
are associated with nonadherence to oral antibiotics include 
prescription of multiple antibiotics and changing health care 
providers for outpatient care [10]. In another study, increased 
dosing frequency negatively impacted oral antibiotic adher-
ence rates [11]. Antibiotics taken once, twice, or 3 times daily 
had adherence rates of 80%, 69%, and 38%, respectively [11]. 
Reasons for missing scheduled oral doses include being away 
from home, asleep, or simply forgetting [10]. However, there is 
a lack of literature on the rates and predictors of nonadherence 
in OPAT.
The Infectious Diseases Society of America recommends 
close clinical follow-up for OPAT patients [12]. Thus, patients’ 
adherence to office visits is a vital component of OPAT care. 
A  recent study showed that attendance at follow-up OPAT 
clinic visits was associated with a lower readmission rate com-
pared with those who had no follow-up visit [13]. Adherence 
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but factors such as transportation, illness, and work commit-
ments impede some patients from attending their scheduled 
appointments [14].
This study aims to quantify the rate of nonadherence 
among OPAT users and understand the reasons leading to 
“no-show” appointments. We conducted a survey to gather de-




The survey was developed in collaboration with an ID physician 
and an ID pharmacist. This survey contained 21 multiple choice 
or Likert-style items and 2 free-text items allowing respondents 
to provide additional comments. The survey was piloted with 
a group of content experts, and questions were modified based 
on their feedback. The survey recorded the respondents’ dem-
ographics, experience with and adherence to OPAT, commu-
nication with health care providers, and barriers to receiving 
optimal OPAT care (Appendix).
Study Population and Distribution
The Infectious Diseases Clinic at Washington University in St. 
Louis School of Medicine monitors patients who are discharged 
from Barnes-Jewish Hospital on OPAT following inpatient care. 
The OPAT program follows 1500 patients annually. About one-
third of the patients are discharged to post–acute care facilities, 
while the rest are discharged home with home health and out-
patient infusion centers. The majority of the patients (50%) 
discharged home on OPAT are cared for by BJC Home Care 
Services, while the rest are covered by multiple different home 
health care agencies such as Coram and Option Care Health. 
Only patients who were discharged home were asked to partici-
pate in the survey. Patients discharged on OPAT were scheduled 
to follow-up with an ID provider in 2 weeks. The appointment 
is usually scheduled before hospital discharge, and the instruc-
tions are printed and handed to the patient upon hospital dis-
charge. For the small number of patients who are discharged 
before appointment scheduling, the clinic staff contact the pa-
tient to make the appointment for the visit. Patients receive an 
automated call from the clinic to remind them about the ap-
pointment 3  days before the visit and a text message 2  days 
before the visit. The most common infection category in our 
OPAT program is bone and joint infections (40%), followed 
by bloodstream infections (21%), intra-abdominal infections 
(11%), and skin and soft tissue infections (8%). The clinic dis-
tributed our surveys to patients returning for their follow-up 
appointments between February and August 2019. Patients 
then placed the confidential, anonymous surveys in a locked 
survey box. The survey was also sent via mail to patients’ home 
addresses on April 29, 2019, and July 22, 2019, to patients who 
had completed their course within the last 30  days. Patients 
were asked to mail the completed survey back to the investiga-
tors in an anonymous, prestamped return envelope. The study 
was approved by the Washington University School of Medicine 
Human Research Protection Office and St. Louis College of 
Pharmacy’s Institutional Review Board.
Data Analysis
Categorical data were presented using frequencies. To analyze 
risk factors associated with nonadherence, we used the Fisher’s 
exact test for categorical variables and the Mann-Whitney U 
test for continuous variables. For multiple choice questions, 
we analyzed the responses based on the percentage of patients 
who answered “agree” or “strongly agree” as opposed to other 
answers. Differences were considered statistically significant if 
P < .05. All quantitative analyses were performed using SAS 9.4 
software (Cary, NC, USA).
We also analyzed qualitative data. Participants were asked 
to answer the free-text questions “Explain the barriers you en-
counter to taking your IV antibiotics as prescribed” and “Please 
use the space below to share any additional information about 
your experience taking IV antibiotics or to elaborate on a ques-
tion listed above.” Three authors (S.D., C.S., and Y.H.) system-
atically read responses and independently categorized them. 
Disagreements were resolved by discussion between the team 
members. Percentages of respondents who answered each item 
and illustrative quotes are presented.
RESULTS
A total of 174 surveys were mailed to adult OPAT patients. 
Twenty-seven (16%) participants responded and completed 
the survey. Additionally, 38 participants completed surveys 
in the clinic during the study period, resulting in a total of 65 
survey responses. Respondents’ median age (interquartile range 
[IQR]) was 62 (53–69) years, and 55% were male. Sixteen re-
spondents (27%) had an annual income below $20 000, and 19 
(33%) were unemployed. Almost half of the respondents had 
to pay a copayment or coinsurance in order to receive IV anti-
biotics (n = 30, 49%). Thirty-five (55%) respondents received 
only 1 IV antibiotic, 17 (27%) received 2, and 12 (19%) received 
at least 3.  Most respondents received intravenous antibiotics 
either once or twice a day (24, 38%, or 19, 30%, respectively). 
Thirty-four respondents (55%) spent at least an hour adminis-
tering their antibiotics, including 14 (23%) who spent 2 hours 
per day (Table 1).
Most respondents (90%) reported strict adherence to IV 
antibiotics, while 6 (10%) reported missing 1–2 doses per week. 
Thirty-seven respondents (60%) reported having no reminder 
system in place, while 28 (45%) reported using an alarm, 
“chart,” or reminder from someone. Thirty-nine respondents 
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antibiotics, and 18 (29%) reported administering IV antibiotics 
independently (Table  1). Respondents contacted a variety of 
health care resources when they had questions about their IV 
antibiotic therapy including home health service (n = 47, 75%), 
pharmacist (n = 22, 35%), or primary physician (n = 21, 33%). 
Most respondents (n = 44, 71%) were compliant with ID doctor 
appointments. Reasons for missed clinic appointments were 
mostly due to lack of transportation in 12 (60%), not feeling 
well in 8 (40%), and being unaware of the appointment in 6 
(30%) responses. In the subset of respondents who answered 
the survey by mail, 18 (62%) reported adherence to clinic visits. 
Among the 11 mail-in respondents who reported missing a 
clinic visit, the most common reasons were not feeling well in 7 
(63%) and lack of transportation in 4 (36%) responses.
Seventeen respondents (27%) felt they spent too much time 
administering antibiotics. Only 4 (6%) said they did not have 
enough time to administer the prescribed antibiotics. Twenty-
one respondents (34%) reported not knowing the side effects of 
their medication, while 6 respondents (10%) reported having a 
serious side effect from the antibiotics (Tables 1–2).
Factors that were associated with medication nonadherence 
included younger age, household income of <$20 000, and not 
having enough time for IV antibiotic administration (30 vs 
64 years, P < .01; 83% vs 20%, P < .01, and 33% vs 4%, P = .04, 
in the nonadherent vs adherent groups, respectively), while less 
frequent administration and having friend or family support 
during IV antibiotic administration were associated with lower 
risk of nonadherence (17% vs 76%, P < .01, and 17% vs 66%, 
P = .03, in the nonadherent vs adherent groups, respectively). 
Lack of knowledge about side effects and medication reminders 
were not found to be associated with nonadherence (Table 3).
A total of 24 patients provided free-text responses about bar-
riers to receipt of IV antibiotics (Table 4). Common barriers in-
cluded difficulties with the administration of antibiotics by the 
Table 1. Characteristics and Responses of 65 Patients who Responded 
to the Survey
Characteristics No. (%) or Median (IQR)
Age, y 62 (53–69)
Sex (female; 58 responses) 26 (44.8)
Annual household income (59 responses)
 <$20 000 16 (27.1)
 $20 000–$50 000 21 (35.6)
 $50 000–$100 000 17 (28.8)
 $100 000+ 5 (8.5)
Employment (57 responses)
 Employed 20 (35.1)
 Unemployed 19 (33.3)
 On disability 18 (31.6)
Does insurance cover cost of antibiotics  
(61 responses)
 All of the cost 30 (49.2)
 Part of the cost 30 (49.2)
 None 1 (1.6)
How many IV antibiotics prescribed  
(64 responses)
 1 35 (54.7)
 2 17 (26.6)
 3 2 (3.1)
 4 or more 10 (15.9)
How often do you take IV antibiotics  
(63 responses)
 Once daily 24 (38.1)
 Twice daily 19 (30.2)
 Three times daily 16 (25.4)
 Other 4 (6.3)
How much time do you spend per day  
taking IV antibiotics (62 responses)
 <30 min 12 (19.4)
 30–60 min 16 (25.8)
 1–2 h 20 (32.3)
 2+ h 14 (22.6)
How many other medications do  
you take (63 responses) 
6 (3–10)
Whom do you ask if you have questions  
about IV antibiotics (63 responses)a
 Home health service 47 (74.6)
 Pharmacy 22 (34.9)
 Primary doctor 21 (33.3)
 Nurse 3 (4.8)
 I wait until next doctor visit 2 (3.2)
If I miss my doctor’s appointment,  
it is because… (62 responses)a
 I have never missed an appointment 44 (71)
Reasons for missed clinic appointment  
(20 of 61 responses)a
 I don’t have a ride 12 (60)
 I don’t feel well 8 (40)
 I was unaware of the appointment 6 (30)
 I don’t have time off work 2 (10)
 I was hospitalized 1 (5)
How do you remember to take your IV  
antibiotics (62 responses)a
 I just remember 37 (59.7)
 I have an alarm set up 14 (22.6)
 Someone reminds me 14 (22.6)
Characteristics No. (%) or Median (IQR)
How many doses of IV antibiotics have  
you missed per week (62 responses)
 1–2 6 (9.7)
 3–4 0
 >4 0
 None 56 (90.3)
Who administers your IV antibiotics  
(63 responses)a
 A family member/friend 39 (61.9)
 Self only 18 (28.6)
 A nurse 6 (9.5)
Abbreviations: IQR, interquartile range; IV, intravenous.
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patient (n = 5, 21%), central line–related issues (n = 5, 21%), 
extensive time needed to administer IV antibiotics (n = 4, 17%), 
challenges with going to doctor appointments while on IV anti-
biotics (n = 3, 13%), medication side effects (n = 2, 8%), and 
limitations in social activities (n = 1, 4%).
Furthermore, 24 respondents provided additional free-text re-
sponses about their overall experience on OPAT. The most common 
themes included were about experiencing side effects (n = 7, 29%) 
and having a great experience with OPAT (n = 5, 21%), whereas 2 
patients (8%) commented about the financial cost of OPAT. As one 
respondent explained, “Out of pocket costs [were] too high. Still 
paying on the $4,000 bill.” One respondent discussed being frus-
trated about not receiving the results of the weekly lab draws. Despite 
the reported challenges with OPAT, 21% of participants providing 
free-text responses felt that the use of OPAT was easy and satisfying. 
As one respondent stated, “Very easy. Anyone can do it” (Table 5).
DISCUSSION
This study examined patient-reported rates of nonadherence 
with OPAT and identified factors associated with nonadherence. 
Overall, patients self-reported relatively high rates of adherence 
to therapy, with 90% of respondents reporting no missed doses 
in an average week. OPAT medication nonadherence was 
found to be disproportionately associated with being young, 
low-income, self-reportedly busy, and without social support. 
Nonadherence to clinical follow-up was more common, as 
29% reported missing an ID appointment. The most common 
reason leading to “no-show” appointments at the ID clinic was 
lack of transportation.
This study supports a strong positive correlation be-
tween medication adherence and age. The median ages of the 
nonadherent and adherent groups were 30 and 64, respectively. 
This may be surprising, as the geriatric population is more prone 
to chronic and recurrent illness, which may require chronic 
medication with multiple drugs. However, others have also 
found that younger adults are more likely to be nonadherent to 
therapy in various other populations [15–18]. Therefore, other 
risk factors such as knowledge of the drug’s purpose, complexity 
of the drug regimen, and type of prescriber should be con-
sidered when planning OPAT treatment regimens [19].
Multiple socioeconomic factors have been found to affect ad-
herence. Higher rates of medication nonadherence have been 
Table 2. Responses of Survey Participants to the Multiple Choice Questions
Likert Scale Question Responses
Agree/Strongly Agree, 
No. (%) Neutral, No. (%)
Disagree/Strongly 
Disagree, No. (%)
I don’t have enough time to administer my antibiotics 4 (6.3) 5 (7.8) 55 (85.9)
I don’t know the side effects of my medications 21 (33.9) 10 (16.1) 31 (50)
I spend too much time administering antibiotics 17 (27.4) 13 (21) 32 (51.6)
I do NOT have a consistent way to get my IV antibiotics 0 4 (6.5) 58 (93.5)
I would like to be able to take my IV antibiotics outside the home 6 (9.8) 13 (21.3) 42 (68.9)
I would be interested in a device that makes it easier to move around during IV 
antibiotic administration
20 (31.7) 23 (36.5) 20 (31.7)
I would be interested in a device that monitors how I take my IV antibiotics and 
shares this information with my doctor
27 (42.9) 25 (39.7) 11 (17.5)
I experience serious side effects from my IV antibiotics 6 (9.7) 9 (14.5) 47 (75.8)
Abbreviation: IV, intravenous.
Table 3. Factors Associated With Nonadherence With IV Antibiotics
Variable
Adherent Patients (n = 56), 
No. (%) or Median (IQR)
Nonadherent Patients (n = 6), 
No. (%) or Median (IQR)
P 
Value
Age, y 64 (57–69) 30 (19–39) <.01
Sex (female) 23 (46) 1 (20) .37
Low income (<$20 000) 10 (19.6) 5 (83.3) <.01
Less frequent administration (daily or twice daily) for 
IV antibiotics
41 (75.9) 1 (16.7) <.01
Family support in administration of IV antibiotics 37 (66.1) 1 (16.7) .03
I spend too much time administering antibiotics 15 (27.3) 2 (33.3) >.99
I don’t have enough time to administer my antibiotics 2 (3.6) 2 (33.3) .04
I would like to be able to take my IV antibiotics out-
side the home
5 (9.4) 1 (16.7) .49
I don’t know the side effects of my medications 20 (37) 1 (16.7) .41
Patient having a reminder set up 21 (38.2) 3 (50) .67
I missed an infectious diseases clinic appointment 16 (29.1) 4 (66.7) .08
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reported in a study assessing low-income, uninsured patients 
[20]. Individuals with lower income tend to be younger, which 
is a known risk factor for nonadherence [21]. Social support 
networks also have an impact on adherence to OPAT. This study 
showed that having a friend or family member assist with IV an-
tibiotic administration was associated with better rates of OPAT 
adherence. This is consistent with prior studies that have shown 
the association between medication adherence and practical so-
cial support, which can be defined as having a family member 
who helps with medications or transportation [22].
Previous studies have found mixed results for using re-
minders as an aid to assist with medication adherence [23, 24]. 
In our study, we did not find an association between reminders 
and adherence. This adds up to a mixed collection of results in 
the literature on the efficacy of reminders across multiple mo-
dalities to improve medication adherence. Vervloet et al. found 
that text message reminders improve medication adherence 
to oral medication in type 2 diabetes patients who are elec-
tronically monitored in real time [23]. Liu et  al. showed that 
reminders from medication monitors improved adherence in 
tuberculosis patients, but text message reminders did not. In 
general, many types of interventions have attempted to improve 
adherence in diverse treatment regimens, but most have failed 
[24].
Our study showed that simpler regimens with once- or twice-
daily dosing were associated with improved adherence to IV 
antibiotics. This is consistent with literature that reports lower 
rates of adherence with multiple administrations per day [11]. 
Unlike oral antibiotics, IV antibiotics require significantly more 
time to administer. In this survey, 55% of patients reported 
spending more than an hour per day to administer the anti-
biotics, with nearly a quarter of all patients spending at least 2 
Table 4. Concerns Raised About Barriers in OPAT
Complaint
Frequency (% of 24 who 
Responded to Item) Illustrative Quote
Difficulty in adminis-
tering IV antibiotics by 
the patient
5 (20.8)  “[I had difficulty in] making sure everything stays sterile while using the medicine”  
“Cannot push plunger slow enough—too difficult to push in all the ml’s over  
such a long time doing it manually”  
 “[I had difficulty] learning how to switch bags. making sure every 8 hours to  
take the oral antibiotic”  
“My girlfriend had to go in the hospital for 2 days and it was hard to do  




5 (20.8) “PICC line isn’t waterproof”  
“[I had a] clog in my IV port”  
“[Had difficulty] changing clothing [while having PICC line in place]”
Time needed to admin-
ister IV antibiotics
4 (16.7) “That it was three times a day and 1.5 hrs each time. Very easily snagged”  
“It takes too long”
Challenges with doctor 
appointments
3 (12.5) “Making appointments around the IV meds”  
“The only time I may have an issue is the time of day. I normally take  
antibiotic around lunch time  
everyday unless I’m at Dr Appointment which may delay the time of  
day its administered”
Medication side effects 2 (8.3) “I had severe side effects to all the medications I was prescribed”
Limitation in social ac-
tivities
1 (4.2) “Not being able to go and socialize while taking them”
Abbreviations: IV, intravenous; OPAT, outpatient parenteral antimicrobial therapy; PICC, peripherally inserted central catheter.
Table 5. Summary of Additional Comments Provided by Patients About Their Experience
Comment
Frequency (% of 24 who 
Responded to Item) Illustrative Quote
Experienced side effects 7 (29.2) “Had allergic reaction and had to stop treatment”  
“The antibiotic I was taking caused constipation and lowered my white blood cell 
count”  
“The side effects were terrible! Especially after 2 weeks! I was happy when it was 
over. Thanks.”
Did have a good experience 5 (20.8) “I was happy with the ability to us[e] the device provided and I didn’t need an IV pole 
like in the hospital”  
“I like taking at home instead of an outpatient location. Especially since its daily. Very 
convenient”  
“Very easy. Anyone can do it”
Financial cost 2 (8.3) “Out of pocket costs [were] too high. Still paying on the $4,000 bill”  
“I called billing 3x with no return call. I have supplies left that I did  
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hours per day. Clinicians should keep this in mind when recom-
mending an OPAT regimen and use simpler regimens when 
feasible.
The strengths of this study include novelty in examining ad-
herence in the OPAT population, of which data are scarce. The 
participants spanned different ages and socioeconomic back-
grounds, allowing us to examine the effects of these factors on 
adherence. This study identified OPAT-specific factors that are 
associated with nonadherence so that clinicians can identify 
those at high risk and address preventable factors to improve 
adherence.
Despite a small sample size, this is the largest study ad-
dressing nonadherence in OPAT. The response rate to the mail 
survey was low; however, this could in part be due to the lack of 
reminders. As the responses were anonymized, we were not able 
to compare the respondents with the nonrespondents to see if 
the 2 groups were different. However, the fact that responses 
came from patients across different age groups and socioeco-
nomic backgrounds improves the generalizability of the survey 
results. Additionally, like other studies, the main limitation of 
the results presented here is a dependency on subjective self-
reporting. These descriptions may be unreliable for 3 different 
reasons: (1) subjects may have forgotten when and how they 
took their medication, (2) they may not have been truthful out 
of the perceived fear that their answers would affect their con-
tinued treatment, or (3) patients who were unconcerned with 
their care may not have answered survey questions, whereas pa-
tients concerned about their health did respond (nonresponder 
bias). We addressed each of these concerns as follows. First, to 
decrease the likelihood of forgetfulness, surveys were adminis-
tered to current patients in the clinic or mailed to patients who 
recently completed their OPAT treatment. Second, patients 
were notified that surveys were anonymous, and identifying 
information was removed. Third, while the nonresponder bias 
might have resulted in a lower response rate from nonadherent 
patients, we collected enough responses from patients who re-
ported nonadherence and were able to identify some risk fac-
tors associated with medication adherence. The outcomes of 
this study can lead to a more efficient workflow that improves 
patient care, medication adherence, and clinic attendance.
CONCLUSIONS
Although younger age, lower income, and lack of time for 
IV antibiotic administration were factors associated with 
nonadherence, less frequent dosing regimens and having friend 
or family support during IV antibiotic administration were pro-
tective. Lack of transportation was also the main risk factor for 
missing follow-up ID  clinic visits. With the information col-
lected in this survey, we garnered a better understanding of this 
patient population, which will lead to targeted efforts to im-
prove care for OPAT patients.
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